Response by Zeitler et al to Letter Regarding Article, "Comparative Effectiveness of Left Atrial Appendage Occlusion Versus Oral Anticoagulation by Sex".

Competing Interests: Disclosures Dr Coylewright reports research funding from Edwards Lifesciences and Boston Scientific and consulting with Edwards Lifesciences, Medtronic, Occlutech, American College of Cardiology, and Boston Scientific. Dr Hsu reports honoraria from Medtronic, Abbott, Boston Scientific, Biotronik, Janssen Pharmaceuticals, Bristol-Myers Squibb, Pfizer, Zoll Medical, Galvanize Therapeutics, Acutus Medical, and Biosense-Webster; research grants from Biotronik and Biosense-Webster; and has equity interest in Vektor Medical. Dr Zeitler reports research funding from Boston Scientific (paid to the institution) and the National Institutes of Health; consulting for Medtronic, Biosense Webster, Boston Scientific, and Sanofi; and nonfinancial research support from Biosense Webster and Sanofi. Dr Al-Khatib reports research funding from Boston Scientific (paid to the institution). Dr Russo reports research funding from Bayer, Boston Scientific, Medilynx, and Medtronic (paid to the institution); consulting for Abbott, Atricure, Bayer, Biosense Webster, Boston Scientific, Medtronic, and PaceMate; honoraria from Biotronik, BMS/Pfizer, Medtronic, and Sanofi; and royalties from UpToDate. The other authors report no disclosures.